WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

PHARMACEUTICAL SYNTHETIC REVIEW OF ROSUVASTATIN CALCIUM

Premchand Patil, Deepak V. Nagarale and *Bhata R. Chaudhari

ABSTRACT

Rosuvastatin is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It was developed by Shionogi. The primary uses of rosuvastatin are for the treatment of dyslipidemia. It is recommended to be used only after other measures such as diet, exercise, and weight reduction have not improved cholesterol levels. Rosuvastatin has multiple contraindications which include hypersensitivity to rosuvastatin or any component of the formulation, active liver disease, and elevation of serum transaminases, pregnancy, or breast-feeding.

Keywords: Rosuvastatin is a member or breast-feeding.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More